R

Recolony AG

5 employees

Recolony is a microbial-based therapy for Colorectal cancer.

Basic info

Industry

biotechnology research

Sectors

Biotechnology

Date founded

2022

Funding rounds raised

Total raised

$162K

from 2 investors over 2 rounds

R

Recolony AG raised $162K on February 21, 2023

Investors: Venture Kick

R

Recolony AG raised $10K on April 28, 2022

Investors: Venture Kick

FAQ